# Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma

> **NCT04594187** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 168 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Immunotherapy
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT04594187
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-26
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594187, "Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04594187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*